316 related articles for article (PubMed ID: 33087132)
1. Discovery of a dual inhibitor of NQO1 and GSTP1 for treating glioblastoma.
Lei K; Gu X; Alvarado AG; Du Y; Luo S; Ahn EH; Kang SS; Ji B; Liu X; Mao H; Fu H; Kornblum HI; Jin L; Li H; Ye K
J Hematol Oncol; 2020 Oct; 13(1):141. PubMed ID: 33087132
[TBL] [Abstract][Full Text] [Related]
2. C/EBPβ mediates NQO1 and GSTP1 anti-oxidative reductases expression in glioblastoma, promoting brain tumor proliferation.
Lei K; Xia Y; Wang XC; Ahn EH; Jin L; Ye K
Redox Biol; 2020 Jul; 34():101578. PubMed ID: 32526700
[TBL] [Abstract][Full Text] [Related]
3. NQO1 Is Regulated by PTEN in Glioblastoma, Mediating Cell Proliferation and Oxidative Stress.
Luo S; Lei K; Xiang D; Ye K
Oxid Med Cell Longev; 2018; 2018():9146528. PubMed ID: 30595797
[TBL] [Abstract][Full Text] [Related]
4. A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis.
Zhong B; Yu J; Hou Y; Ai N; Ge W; Lu JJ; Chen X
Free Radic Biol Med; 2021 Apr; 166():104-115. PubMed ID: 33600944
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic Screening of Chemical Libraries Enriched by Molecular Docking to Multiple Targets Selected from Glioblastoma Genomic Data.
Xu D; Zhou D; Bum-Erdene K; Bailey BJ; Sishtla K; Liu S; Wan J; Aryal UK; Lee JA; Wells CD; Fishel ML; Corson TW; Pollok KE; Meroueh SO
ACS Chem Biol; 2020 Jun; 15(6):1424-1444. PubMed ID: 32243127
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphorylation of the human glutathione S-transferase P1 by epidermal growth factor receptor.
Okamura T; Singh S; Buolamwini J; Haystead T; Friedman H; Bigner D; Ali-Osman F
J Biol Chem; 2009 Jun; 284(25):16979-16989. PubMed ID: 19254954
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of Glutathione S-Transferase P1 (GSTP1) by Epidermal Growth Factor Receptor (EGFR) Promotes Formation of the GSTP1-c-Jun N-terminal kinase (JNK) Complex and Suppresses JNK Downstream Signaling and Apoptosis in Brain Tumor Cells.
Okamura T; Antoun G; Keir ST; Friedman H; Bigner DD; Ali-Osman F
J Biol Chem; 2015 Dec; 290(52):30866-78. PubMed ID: 26429914
[TBL] [Abstract][Full Text] [Related]
8. Human NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated inactivation of reactive quinoneimine metabolites of diclofenac and mefenamic acid.
Vredenburg G; Elias NS; Venkataraman H; Hendriks DF; Vermeulen NP; Commandeur JN; Vos JC
Chem Res Toxicol; 2014 Apr; 27(4):576-86. PubMed ID: 24552538
[TBL] [Abstract][Full Text] [Related]
9. 2-Methoxy-6-acetyl-7-methyljuglone (MAM) induced programmed necrosis in glioblastoma by targeting NAD(P)H: Quinone oxidoreductase 1 (NQO1).
Yu J; Zhong B; Jin L; Hou Y; Ai N; Ge W; Li L; Liu S; Lu JJ; Chen X
Free Radic Biol Med; 2020 May; 152():336-347. PubMed ID: 32234332
[TBL] [Abstract][Full Text] [Related]
10. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.
Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H
Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878
[TBL] [Abstract][Full Text] [Related]
11. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
12. Candidate dietary phytochemicals modulate expression of phase II enzymes GSTP1 and NQO1 in human lung cells.
Tan XL; Shi M; Tang H; Han W; Spivack SD
J Nutr; 2010 Aug; 140(8):1404-10. PubMed ID: 20554899
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer.
Wu X; Li X; Li Z; Yu Y; You Q; Zhang X
J Med Chem; 2018 Dec; 61(24):11280-11297. PubMed ID: 30508483
[TBL] [Abstract][Full Text] [Related]
14. Combined GSTP1 and NQO1 germline polymorphisms in the susceptibility to Multiple Sclerosis.
Alexoudi A; Zachaki S; Stavropoulou C; Chatzi I; Koumbi D; Stavropoulou K; Kollia P; Karageorgiou CE; Sambani C
Int J Neurosci; 2015 Jan; 125(1):32-7. PubMed ID: 24588223
[TBL] [Abstract][Full Text] [Related]
15. NQO1 drives glioblastoma cell aggressiveness through EMT induction via the PI3K/Akt/mTOR/Snail pathway.
Zheng L; Yang S; Xu R; Yang Y; Quan J; Lin Z; Quan C
Int J Oncol; 2023 Oct; 63(4):. PubMed ID: 37594082
[TBL] [Abstract][Full Text] [Related]
16. Discovery of quinone-directed antitumor agents selectively bioactivated by NQO1 over CPR with improved safety profile.
Bian J; Li X; Wang N; Wu X; You Q; Zhang X
Eur J Med Chem; 2017 Mar; 129():27-40. PubMed ID: 28214631
[TBL] [Abstract][Full Text] [Related]
17. Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
Costa B; Bendinelli S; Gabelloni P; Da Pozzo E; Daniele S; Scatena F; Vanacore R; Campiglia P; Bertamino A; Gomez-Monterrey I; Sorriento D; Del Giudice C; Iaccarino G; Novellino E; Martini C
PLoS One; 2013; 8(8):e72281. PubMed ID: 23977270
[TBL] [Abstract][Full Text] [Related]
18. Betulin-1,4-quinone hybrids: Synthesis, anticancer activity and molecular docking study with NQO1 enzyme.
Kadela-Tomanek M; Bębenek E; Chrobak E; Marciniec K; Latocha M; Kuśmierz D; Jastrzębska M; Boryczka S
Eur J Med Chem; 2019 Sep; 177():302-315. PubMed ID: 31158746
[TBL] [Abstract][Full Text] [Related]
19. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
[TBL] [Abstract][Full Text] [Related]
20. GSTM1, GSTP1, and NQO1 polymorphisms and susceptibility to atopy and airway hyperresponsiveness among South African schoolchildren.
Reddy P; Naidoo RN; Robins TG; Mentz G; London SJ; Li H; Naidoo R
Lung; 2010 Oct; 188(5):409-14. PubMed ID: 20526719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
